The cancer type and level of risk varies for each individual risky gene carrier. This depends on the type of mutation(s) carried, in which gene it exists, the number and relationship of biological relatives that have developed hereditary cancer and a variety of other factors. Cancer risk is usually determined by a qualified genetic counsellor at the time genetic test results are received.
Cancer screening will not actually reduce your risk of developing cancer. The goal is to find a cancer as early as possible, when treatment is likely to be most effective. Increased screening for breast and ovarian cancer is recommended as early as the age of 25 and prostate cancer at the age of 40.
Screening recommendations may vary by region but are likely to include:
■ practicing self-awareness
■ breast screening (e.g. mammogram, MRI)
■ abdominal exam
■ ovarian screening (internal ultrasound, CA 125)
■ cervical screening
■ prostate exam (including PSA)
■ screening for other types of cancer
Ask your medical professionals about the options available for your particular situation.
NOTE: Some communities have specialized clinics that provide or facilitate services that include cancer screening for those at high risk of developing breast and ovarian cancer. However, these services often face high volumes that result in long wait times. In the meantime, ask your primary care physician to book the appointments for you.
Copyright © 2021 Risky Genes - All Rights Reserved.
Disclaimer: This website is for educational and informational purposes only and may not be construed as medical advice, nor is this information intended to replace advice offered by medical professionals.
We will be dissolving The Risky Genes Society over the next few months and dispersing all remaining assets as required according to the Alberta Societies Act and Canada Income Tax Act. We wish all those affected by hereditary cancer a future of growing knowledge and awareness of how hereditary cancer can be prevented, detected and treated. All the best in health to those affected with hereditary cancer.
Feel free to explore our website but be aware that it is not being maintained.